Alchemy, a US company that builds in-house pharmacies for safety net clinics, announced on Thursday that it has collaborated with PatchRx, a developer of medication adherence technology, to tackle HIV medication adherence.
The partnership addresses this issue by combining Alchemy's comprehensive pharmacy infrastructure with PatchRx's smart pill bottle technology. Safety net clinics that serve large HIV positive populations will be provided with real-time medication adherence data through PatchRx's patented smart pill bottle caps, integrated directly into Alchemy's pharmacy OS.
This combination offers providers and pharmacists greater visibility into patient medication adherence, enabling personalised intervention, and ultimately improving HIV medication adherence rates and health outcomes.
Alume Biosciences names new chief commercial officer
genedrive plc secures initial UK order for Genedrive CYP2C19-ID Kit
Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial
Gilead study suggests lenacapavir superior to Truvada
Oxford BioDynamics announces opening of clinical testing facility in UK for prostate screening test
Micron Biomedical names new scientific advisor to CEO
China accepts GSK's Shingrix application for at-risk adults
Takeda's HyQvia approved for maintenance therapy in CIDP patients
Allurion's Gastric Balloon introduced at Somerset NHS Foundation Trust for pre-surgical weight loss
Takeda's HYQVIA gains FDA approval for CIDP maintenance therapy